---
$id: https://graph.org.ai/products/commodity/51111773
$type: Product
source: UNSPSC
code: "51111773"
title: "Vinzolidine"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vinzolidine

**UNSPSC Code**: 51111773
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca-site binding agent with the molecular formula C48H58ClN5O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 533U947V6Q, chemically known as 2h-3,7-methanoazacycloundecino(5,4-b)indole-9-carboxylic acid, 9-((2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-3-(2-chloroethyl)-6,7-didehydro-16-methoxy-1-methyl-2,4-dioxospiro(aspidospermidine-3,5-oxazolidin)-15-yl)-5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-, methyl ester, (3r-(3r*,5s*,7r*,9s*))- but generally known as vinzolidine, which bears US NIH Compound Identifier 49966. Most nations schedule vinzolidine under HS 29399900 and SITC 54149. As of Q4 2014, VINZOLIDINE remains the US FDA Preferred Term for this commodity. Vinzolidine bears US NLM identifiers UMLS ID C0078282 and NCI Concept Code C1276. SMILES: CLCCN1C(=O)C2(OC1=O)C1N(C3C(C41C1N(CC4)CC=CC1(C2OC(=O)C)CC)CC(C(OC)C3)C1(CC2CC(O)(CN(C2)CCC2C1[NH]C1C2CCCC1)CC)C(=O)OC)C.

